Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
57
HMC Quote, Financials, Valuation and Earnings
Last price:
$30.35
Seasonality move
:
-0.45%
Day range:
$30.26 - $30.56
52-week range:
$23.41 - $33.72
Dividend yield:
4.53%
P/E ratio:
8.74x
P/S ratio:
0.33x
P/B ratio:
0.51x
Volume:
851.1K
Avg. volume:
947.2K
1-year change:
-6.17%
Market cap:
$41.7B
Revenue:
$142.4B
EPS (TTM):
$3.50
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $124.2B | $129.6B | $125.2B | $141.6B | $142.4B | |
| Revenue Growth (YoY) | -9.56% | 4.34% | -3.41% | 13.06% | 0.58% | |
| Cost of Revenues | $98.5B | $103B | $100.5B | $111B | $111.8B | |
| Gross Profit | $25.8B | $26.6B | $24.7B | $30.6B | $30.6B | |
| Gross Profit Margin | 20.73% | 20.51% | 19.71% | 21.6% | 21.5% | |
| R&D Expenses | $7B | $7B | $6.5B | $6.4B | $7.2B | |
| Selling, General & Admin | $12.6B | $11.8B | $12.4B | $14.6B | $15.4B | |
| Other Inc / (Exp) | $2.5B | $1.8B | $586.2M | $1.3B | -$202M | |
| Operating Expenses | $19.5B | $18.8B | $18.9B | $21B | $22.7B | |
| Operating Income | $6.2B | $7.8B | $5.8B | $9.6B | $8B | |
| Net Interest Expenses | $105.7M | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.6B | $9.5B | $6.5B | $11.4B | $8.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1B | $2.8B | $1.2B | $3.2B | $2.7B | |
| Net Income to Company | $8.6B | $9.5B | $6.5B | $11.4B | $8.7B | |
| Minority Interest in Earnings | -$358.6M | -$477.8M | -$488M | -$522.6M | -$441.2M | |
| Net Income to Common Excl Extra Items | $6.2B | $6.3B | $4.8B | $7.7B | $5.5B | |
| Basic EPS (Cont. Ops) | $3.59 | $3.66 | $2.84 | $4.70 | $3.52 | |
| Diluted EPS (Cont. Ops) | $3.59 | $3.66 | $2.84 | $4.70 | $3.52 | |
| Weighted Average Basic Share | $1.7B | $1.7B | $1.7B | $1.6B | $1.6B | |
| Weighted Average Diluted Share | $1.7B | $1.7B | $1.7B | $1.6B | $1.6B | |
| EBITDA | $14.6B | $15.1B | $12.1B | $17.3B | $13.9B | |
| EBIT | $8.8B | $9.7B | $6.8B | $11.8B | $9B | |
| Revenue (Reported) | $124.2B | $129.6B | $125.2B | $141.6B | $142.4B | |
| Operating Income (Reported) | $6.2B | $7.8B | $5.8B | $9.6B | $8B | |
| Operating Income (Adjusted) | $8.8B | $9.7B | $6.8B | $11.8B | $9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $34.2B | $33.4B | $33.2B | $36.6B | $35.2B | |
| Revenue Growth (YoY) | 7.76% | -2.5% | -0.51% | 10.21% | -3.91% | |
| Cost of Revenues | $26.9B | $26.5B | $26.7B | $28.8B | $27.7B | |
| Gross Profit | $7.4B | $6.8B | $6.5B | $7.8B | $7.5B | |
| Gross Profit Margin | 21.49% | 20.5% | 19.47% | 21.19% | 21.23% | |
| R&D Expenses | $2.2B | $1.9B | $2.1B | $2B | $2.3B | |
| Selling, General & Admin | $3.1B | $3.2B | $4B | $3.7B | $4.7B | |
| Other Inc / (Exp) | $571M | $348.6M | -$527.9M | $805.6M | -$23M | |
| Operating Expenses | $5.3B | $5.1B | $6.1B | $5.7B | $7B | |
| Operating Income | $2B | $1.7B | $354.5M | $2.1B | $482.4M | |
| Net Interest Expenses | $173.1M | $130.3M | -- | $318.7M | $63.8M | |
| EBT. Incl. Unusual Items | $2.4B | $1.9B | $152.8M | $2.5B | $603.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $300.3M | $692.5M | -$478.8M | $808.3M | $324.5M | |
| Net Income to Company | $2.3B | $2.1B | $418M | $2.8B | $615.7M | |
| Minority Interest in Earnings | -$96.5M | -$168.7M | -$115M | -$137M | -$78.9M | |
| Net Income to Common Excl Extra Items | $2B | $1.1B | $516.7M | $1.6B | $200.5M | |
| Basic EPS (Cont. Ops) | $1.17 | $0.63 | $0.32 | $0.99 | $0.18 | |
| Diluted EPS (Cont. Ops) | $1.17 | $0.63 | $0.32 | $0.99 | $0.18 | |
| Weighted Average Basic Share | $1.7B | $1.7B | $1.7B | $1.6B | $1.5B | |
| Weighted Average Diluted Share | $1.7B | $1.7B | $1.7B | $1.6B | $1.5B | |
| EBITDA | $4.2B | $3.3B | $1.6B | $4B | $2B | |
| EBIT | $2.5B | $2B | $235.3M | $2.7B | $714.5M | |
| Revenue (Reported) | $34.2B | $33.4B | $33.2B | $36.6B | $35.2B | |
| Operating Income (Reported) | $2B | $1.7B | $354.5M | $2.1B | $482.4M | |
| Operating Income (Adjusted) | $2.5B | $2B | $235.3M | $2.7B | $714.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $124.5B | $129.5B | $125B | $141.3B | $142.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $98.6B | $102.9B | $100.4B | $110.8B | $111.8B | |
| Gross Profit | $25.8B | $26.6B | $24.6B | $30.5B | $30.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $7B | $7B | $6.5B | $6.4B | $7.2B | |
| Selling, General & Admin | $12.6B | $11.8B | $12.4B | $14.5B | $15.5B | |
| Other Inc / (Exp) | $2.5B | $1.8B | $551.1M | $1.3B | -$205.9M | |
| Operating Expenses | $19.5B | $18.8B | $18.9B | $20.9B | $22.7B | |
| Operating Income | $6.3B | $7.8B | $5.7B | $9.6B | $7.9B | |
| Net Interest Expenses | $104.9M | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.7B | $9.5B | $6.4B | $11.4B | $8.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1B | $2.8B | $1.2B | $3.2B | $2.7B | |
| Net Income to Company | $8.6B | $9.5B | $6.5B | $11.4B | $8.7B | |
| Minority Interest in Earnings | -$360.6M | -$474.5M | -$485.9M | -$523M | -$440M | |
| Net Income to Common Excl Extra Items | $6.3B | $6.3B | $4.8B | $7.7B | $5.4B | |
| Basic EPS (Cont. Ops) | $3.62 | $3.67 | $2.82 | $4.72 | $3.50 | |
| Diluted EPS (Cont. Ops) | $3.62 | $3.67 | $2.82 | $4.72 | $3.50 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $14.7B | $15.1B | $12B | $17.3B | $13.8B | |
| EBIT | $8.8B | $9.7B | $6.7B | $11.8B | $9B | |
| Revenue (Reported) | $124.5B | $129.5B | $125B | $141.3B | $142.4B | |
| Operating Income (Reported) | $6.3B | $7.8B | $5.7B | $9.6B | $7.9B | |
| Operating Income (Adjusted) | $8.8B | $9.7B | $6.7B | $11.8B | $9B | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $129.5B | $125B | $141.3B | $142.4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $102.9B | $100.4B | $110.8B | $111.8B | -- | |
| Gross Profit | $26.6B | $24.6B | $30.5B | $30.6B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $7B | $6.5B | $6.4B | $7.2B | -- | |
| Selling, General & Admin | $11.8B | $12.4B | $14.5B | $15.5B | -- | |
| Other Inc / (Exp) | $1.8B | $551.1M | $1.3B | -$205.9M | -- | |
| Operating Expenses | $18.8B | $18.9B | $20.9B | $22.7B | -- | |
| Operating Income | $7.8B | $5.7B | $9.6B | $7.9B | -- | |
| Net Interest Expenses | $141.8M | $172.9M | $318.7M | $422.2M | -- | |
| EBT. Incl. Unusual Items | $9.5B | $6.4B | $11.4B | $8.6B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.8B | $1.2B | $3.2B | $2.7B | -- | |
| Net Income to Company | $9.5B | $6.5B | $11.4B | $8.7B | -- | |
| Minority Interest in Earnings | -$474.5M | -$485.9M | -$523M | -$440M | -- | |
| Net Income to Common Excl Extra Items | $6.3B | $4.8B | $7.7B | $5.4B | -- | |
| Basic EPS (Cont. Ops) | $3.67 | $2.82 | $4.72 | $3.50 | -- | |
| Diluted EPS (Cont. Ops) | $3.67 | $2.82 | $4.72 | $3.50 | -- | |
| Weighted Average Basic Share | $6.9B | $6.8B | $6.5B | $6.2B | -- | |
| Weighted Average Diluted Share | $6.9B | $6.8B | $6.5B | $6.2B | -- | |
| EBITDA | $15.1B | $12B | $17.3B | $13.8B | -- | |
| EBIT | $9.7B | $6.7B | $11.8B | $9B | -- | |
| Revenue (Reported) | $129.5B | $125B | $141.3B | $142.4B | -- | |
| Operating Income (Reported) | $7.8B | $5.7B | $9.6B | $7.9B | -- | |
| Operating Income (Adjusted) | $9.7B | $6.7B | $11.8B | $9B | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $25B | $30.1B | $28.5B | $32.7B | $30.3B | |
| Short Term Investments | $2.7B | $1.8B | $2B | $1.5B | $1.4B | |
| Accounts Receivable, Net | $23.5B | $21.2B | $22.2B | $25.1B | $26.2B | |
| Inventory | $14B | $15.7B | $16.3B | $16.1B | $16.5B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.5B | $3.6B | $2.9B | $3B | $3.8B | |
| Total Current Assets | $68.7B | $72.4B | $71.9B | $78.4B | $78.1B | |
| Property Plant And Equipment | $72B | $67.5B | $59.2B | $55.7B | $59.9B | |
| Long-Term Investments | $13.8B | $14.6B | $13.3B | $14.4B | $14.1B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $7.4B | $7B | $6.5B | $6.6B | $7.5B | |
| Other Long-Term Assets | $3.1B | $3.5B | $3.4B | $3.3B | $3.8B | |
| Total Assets | $198.7B | $196.4B | $185.1B | $196.7B | $205.7B | |
| Accounts Payable | $9.9B | $10.1B | $10.7B | $10.6B | $11.1B | |
| Accrued Expenses | $3.8B | $3.1B | $3.1B | $4.2B | $4.9B | |
| Current Portion Of Long-Term Debt | $19.3B | $21.7B | $17.1B | $19.7B | $21B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $7.5B | $7.9B | $8.3B | $8.8B | $8.7B | |
| Total Current Liabilities | $51.8B | $49.2B | $49.9B | $55B | $57.6B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $113.7B | $108.2B | $98.8B | $110.8B | $121.3B | |
| Common Stock | $780.2M | $705.1M | $645.9M | $568.6M | $575.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $82.3B | $85.8B | $83.9B | $83.9B | $82.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.6B | $2.5B | $2.4B | $2B | $2B | |
| Total Equity | $85B | $88.3B | $86.3B | $85.9B | $84.4B | |
| Total Liabilities and Equity | $198.7B | $196.4B | $185.1B | $196.7B | $205.7B | |
| Cash and Short Terms | $27.7B | $31.9B | $30.5B | $34.3B | $31.7B | |
| Total Debt | $26.9B | $25.1B | $24.4B | $26.6B | $29.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $25B | $30.1B | $28.5B | $32.7B | $30.3B | |
| Short Term Investments | $2.7B | $1.8B | $2B | $1.5B | $1.4B | |
| Accounts Receivable, Net | $23.5B | $21.2B | $22.2B | $25.1B | $26.2B | |
| Inventory | $14B | $15.7B | $16.3B | $16.1B | $16.5B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.5B | $3.6B | $2.9B | $3B | $3.8B | |
| Total Current Assets | $68.7B | $72.4B | $71.9B | $78.4B | $78.1B | |
| Property Plant And Equipment | $72B | $67.5B | $59.2B | $55.7B | $59.9B | |
| Long-Term Investments | $13.8B | $14.6B | $13.3B | $14.4B | $14.1B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $7.4B | $7B | $6.5B | $6.6B | $7.5B | |
| Other Long-Term Assets | $3.1B | $3.5B | $3.4B | $3.3B | $3.8B | |
| Total Assets | $198.7B | $196.4B | $185.1B | $196.7B | $205.7B | |
| Accounts Payable | $9.9B | $10.1B | $10.7B | $10.6B | $11.1B | |
| Accrued Expenses | $3.8B | $3.1B | $3.1B | $4.2B | $4.9B | |
| Current Portion Of Long-Term Debt | $19.3B | $21.7B | $17.1B | $19.7B | $21B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $7.5B | $7.9B | $8.3B | $8.8B | $8.7B | |
| Total Current Liabilities | $51.8B | $49.2B | $49.9B | $55B | $57.6B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $113.7B | $108.2B | $98.8B | $110.8B | $121.3B | |
| Common Stock | $780.2M | $705.1M | $645.9M | $568.6M | $575.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.6B | $2.5B | $2.4B | $2B | $2B | |
| Total Equity | $85B | $88.3B | $86.3B | $85.9B | $84.4B | |
| Total Liabilities and Equity | $198.7B | $196.4B | $185.1B | $196.7B | $205.7B | |
| Cash and Short Terms | $27.7B | $31.9B | $30.5B | $34.3B | $31.7B | |
| Total Debt | $26.9B | $25.1B | $24.4B | $26.6B | $29.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.6B | $9.5B | $6.5B | $11.4B | $8.7B | |
| Depreciation & Amoritzation | $5.9B | $5.4B | $5.3B | $5.5B | $4.9B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.8B | $4.3B | -$1.5B | -$11B | -$5.5B | |
| Change in Inventories | $644.1M | -$1.9B | -$1.3B | -$470.1M | -$521.7M | |
| Cash From Operations | $10.1B | $15B | $15.8B | $5.2B | $1.9B | |
| Capital Expenditures | $5.2B | $4B | $4.7B | $4.2B | $5.6B | |
| Cash Acquisitions | -$905.1M | -- | -$171M | -$1.3B | -$889.8M | |
| Cash From Investing | -$7.5B | -$3.3B | -$5B | -$6B | -$6.2B | |
| Dividends Paid (Ex Special Dividend) | -$1.4B | -$1.7B | -$1.6B | -$1.7B | -$2.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $104.4B | $84.5B | $74.8B | $94.8B | $84B | |
| Long-Term Debt Repaid | -$105.3B | -$87.3B | -$82.5B | -$84.4B | -$74.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$399.1M | -$479.3M | -$380.5M | -$578.4M | -$414.5M | |
| Cash From Financing | -$2.7B | -$5.5B | -$10.9B | $6.4B | $1.8B | |
| Beginning Cash (CF) | $25.2B | $24.6B | $27.2B | $26.4B | $32.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$80M | $6.1B | -$128.8M | $5.5B | -$2.4B | |
| Ending Cash (CF) | $26B | $32.7B | $28.2B | $34.3B | $29.7B | |
| Levered Free Cash Flow | $4.9B | $11B | $11.1B | $960.6M | -$3.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.3B | $2.1B | $418M | $2.8B | $615.7M | |
| Depreciation & Amoritzation | $1.6B | $1.4B | $1.5B | $1.4B | $1.3B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.8B | $613.9M | -$3.3B | -$2.6B | -$1.8B | |
| Change in Inventories | -$199.1M | -$94.3M | -$432M | $47.5M | -$317.6M | |
| Cash From Operations | $2.2B | $6.6B | $3.6B | $2.3B | $912.8M | |
| Capital Expenditures | $1.4B | $1.1B | $1.1B | $1.6B | $1.9B | |
| Cash Acquisitions | $34.6M | -- | -$97.6M | -$575.4M | -$379.3M | |
| Cash From Investing | -$1.2B | $8.7M | -$874.1M | -$2.3B | -$2B | |
| Dividends Paid (Ex Special Dividend) | -$409.5M | -$20.9M | -$66.7M | -$38M | -$3.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $24.4B | $22.1B | $23.3B | $23.5B | $24.3B | |
| Long-Term Debt Repaid | -$27.4B | -$21.4B | -$24.1B | -$20.1B | -$22.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$67M | -$112.3M | -$95.2M | -$151.5M | -$109.2M | |
| Cash From Financing | -$3.5B | $604M | -$1.5B | $3B | -$773.3M | |
| Beginning Cash (CF) | $27.5B | $23.7B | $25.5B | $29.4B | $32.5B | |
| Foreign Exchange Rate Adjustment | $1.3B | $1.5B | $290.7M | $1.4B | -$967.7M | |
| Additions / Reductions | -$2.4B | $7.2B | $1.2B | $2.9B | -$1.9B | |
| Ending Cash (CF) | $26B | $32.7B | $28.2B | $34.3B | $29.7B | |
| Levered Free Cash Flow | $769.1M | $5.5B | $2.5B | $764.2M | -$990.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.6B | $9.5B | $6.5B | $11.4B | $8.7B | |
| Depreciation & Amoritzation | $5.9B | $5.4B | $5.3B | $5.5B | $4.9B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.8B | $4.3B | -$1.5B | -$11B | -$5.5B | |
| Change in Inventories | $644.1M | -$1.9B | -$1.3B | -$470.1M | -$521.7M | |
| Cash From Operations | $10.1B | $15B | $15.8B | $5.2B | $1.9B | |
| Capital Expenditures | $5.2B | $4B | $4.7B | $4.2B | $5.6B | |
| Cash Acquisitions | -$905.1M | -- | -$171M | -$1.3B | -$889.8M | |
| Cash From Investing | -$7.5B | -$3.3B | -$5B | -$6B | -$6.2B | |
| Dividends Paid (Ex Special Dividend) | -$1.4B | -$1.7B | -$1.6B | -$1.7B | -$2.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $104.4B | $84.5B | $74.8B | $94.8B | $84B | |
| Long-Term Debt Repaid | -$105.3B | -$87.3B | -$82.5B | -$84.4B | -$74.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$399.1M | -$479.3M | -$380.5M | -$578.4M | -$414.5M | |
| Cash From Financing | -$2.7B | -$5.5B | -$10.9B | $6.4B | $1.8B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$80M | $6.1B | -$128.8M | $5.5B | -$2.4B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $4.9B | $11B | $11.1B | $960.6M | -$3.6B | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.5B | $6.5B | $11.4B | $8.7B | -- | |
| Depreciation & Amoritzation | $5.4B | $5.3B | $5.5B | $4.9B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $4.3B | -$1.5B | -$11B | -$5.5B | -- | |
| Change in Inventories | -$1.9B | -$1.3B | -$470.1M | -$521.7M | -- | |
| Cash From Operations | $15B | $15.8B | $5.2B | $1.9B | -- | |
| Capital Expenditures | $4B | $4.7B | $4.2B | $5.6B | -- | |
| Cash Acquisitions | -- | -$171M | -$1.3B | -$889.8M | -- | |
| Cash From Investing | -$3.3B | -$5B | -$6B | -$6.2B | -- | |
| Dividends Paid (Ex Special Dividend) | -$1.7B | -$1.6B | -$1.7B | -$2.3B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $84.5B | $74.8B | $94.8B | $84B | -- | |
| Long-Term Debt Repaid | -$87.3B | -$82.5B | -$84.4B | -$74.7B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$479.3M | -$380.5M | -$578.4M | -$414.5M | -- | |
| Cash From Financing | -$5.5B | -$10.9B | $6.4B | $1.8B | -- | |
| Beginning Cash (CF) | $95.5B | $110.4B | $117.6B | $127.4B | -- | |
| Foreign Exchange Rate Adjustment | $2B | $1.1B | $2.4B | -$370.5M | -- | |
| Additions / Reductions | $6.1B | -$128.8M | $5.5B | -$2.4B | -- | |
| Ending Cash (CF) | $103.1B | $110.2B | $124.3B | $125.3B | -- | |
| Levered Free Cash Flow | $11B | $11.1B | $960.6M | -$3.6B | -- | |
Get HMC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HMC
Sector
P/E ratio
8.74x
16.92x
PEG ratio
1.04x
0.17x
P/B ratio
0.51x
1.42x
Price / LTM sales
0.33x
0.68x
Growth Metrics
HMC
Sector
Revenue growth
-3.91%
0.64%
Earnings growth
-81.68%
-1.02%
Revenue (5-year growth)
0.72%
3.61%
Earnings forecast
--
$0.24
Profitability
HMC
Sector
Profitability FY 2024
$30.6B
$456.7M
Return on invested capital
5.61%
4.58%
Return on assets
2.72%
2.72%
Return on equity
6.34%
6.7%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
12
Balance Sheet
HMC
Sector
Total cash
$31.7B
$139.6M
Short term investments
$1.4B
$46.8M
Total assets
$205.7B
$1.4B
Long term debt
$29.6B
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
